H.C. Wainwright Reiterates Buy on Microbot Medical, Raises Price Target to $26

H.C. Wainwright reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and raises the price target from $12 to $26.

Benzinga · 01/13/2020 12:36

H.C. Wainwright reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and raises the price target from $12 to $26.